Is This Southeast Asian Nation the New Destination for Celltrion's Expansion? - an Industrial Info Market Brief

South Korean bio-pharma major Celltrion Incorporated is looking south to set up its massive 360,000-litre biologicals plant. The company earlier shelved its plans for a third plant at the company's home site in Incheon for an undisclosed overseas location, saying the move will help ensure supplies to its global partners. Industrial Info has tracked down the $800 million project to a Southeast Asian, which is intended to support the production of its upcoming biosimilars.